ALLOVANCE Trademark

Trademark Overview

On Wednesday, November 23, 2016, a trademark application was filed for ALLOVANCE with the United States Patent and Trademark Office. The USPTO has given the ALLOVANCE trademark a serial number of 79203792. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2018. This trademark is owned by Australian Biotechnologies Pty Limited. The ALLOVANCE trademark is filed in the Pharmaceutical Products category with the following description:

Biological tissue cultures for medical purposes; guided tissue regeneration materials, namely, implants comprising living tissue; implant materials for use in guided tissue regeneration in surgery, namely, implants comprising living tissue; implantable textile material comprising living tissue to encourage the growth of tissue; implants for guided tissue regeneration, namely, implants comprising living tissue; surgical grafts comprised of living tissues; surgical implants comprised of living tissues; surgical implants grown from stem cells comprised of living tissues; tissue-regenerative medical preparations; transplants comprised of living tissues, namely, implants comprising living tissue, biological tissue grafts; materials for use in guided tissue regeneration, namely, implants comprising living tissue
allovance

General Information

Serial Number79203792
Word MarkALLOVANCE
Filing DateWednesday, November 23, 2016
Status700 - REGISTERED
Status DateTuesday, February 20, 2018
Registration Number5403900
Registration DateTuesday, February 20, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements

Goods and ServicesBiological tissue cultures for medical purposes; guided tissue regeneration materials, namely, implants comprising living tissue; implant materials for use in guided tissue regeneration in surgery, namely, implants comprising living tissue; implantable textile material comprising living tissue to encourage the growth of tissue; implants for guided tissue regeneration, namely, implants comprising living tissue; surgical grafts comprised of living tissues; surgical implants comprised of living tissues; surgical implants grown from stem cells comprised of living tissues; tissue-regenerative medical preparations; transplants comprised of living tissues, namely, implants comprising living tissue, biological tissue grafts; materials for use in guided tissue regeneration, namely, implants comprising living tissue
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAustralian Biotechnologies Pty Limited
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressFRENCHS FOREST NSW 2086
AU
Party NameAustralian Biotechnologies Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressFRENCHS FOREST NSW 2086
AU
Party NameAustralian Biotechnologies Pty Limited
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressFRENCHS FOREST NSW 2086
AU

Trademark Events

Event DateEvent Description
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 7, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, March 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 20, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 13, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 29, 2018FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 29, 2018FINAL DISPOSITION PROCESSED
Sunday, May 20, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 8, 2017NOTIFICATION PROCESSED BY IB
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 31, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, October 31, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 31, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, October 31, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, October 12, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 22, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 30, 2017ASSIGNED TO LIE
Friday, September 22, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 22, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 5, 2017ASSIGNED TO EXAMINER
Saturday, April 22, 2017REFUSAL PROCESSED BY IB
Tuesday, April 4, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 4, 2017REFUSAL PROCESSED BY MPU
Saturday, April 1, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 31, 2017NON-FINAL ACTION WRITTEN
Friday, March 31, 2017APPLICATION FILING RECEIPT MAILED
Monday, March 27, 2017ASSIGNED TO EXAMINER
Monday, March 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 23, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

allovance tissue living implants comprising namely tissues regeneration guided comprised materials